{
    "accountDetails": {
        "accountHasCodexViolations": false,
        "activeDateRanges": [
            {
                "fromDate": "2022-10-11T13:53:38.000+02:00"
            }
        ],
        "firstPublicationDate": "2022-07-15T14:52:11.000+02:00",
        "lastUpdateDate": "2024-08-16T14:46:12.000+02:00",
        "registerEntryVersions": [
            {
                "legislation": "GL2024",
                "registerEntryId": 39303,
                "validFromDate": "2024-08-16T14:46:12.000+02:00",
                "version": 5,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2024",
                "registerEntryId": 37369,
                "validFromDate": "2024-06-25T16:51:16.000+02:00",
                "validUntilDate": "2024-08-16T14:46:12.000+02:00",
                "version": 4,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 23650,
                "validFromDate": "2023-07-13T18:52:01.000+02:00",
                "validUntilDate": "2024-06-25T16:51:16.000+02:00",
                "version": 3,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 10298,
                "validFromDate": "2022-10-11T13:53:38.000+02:00",
                "validUntilDate": "2023-07-13T18:52:01.000+02:00",
                "version": 2,
                "versionActiveLobbyist": true
            }
        ]
    },
    "activeLobbyist": true,
    "activitiesAndInterests": {
        "activity": {
            "code": "ACT_ORGANIZATION_V2",
            "de": "Sonstiges Unternehmen",
            "en": "Other company"
        },
        "activityDescription": "Vertretung der Interessen von ALK-Abell\u00f3 gegen\u00fcber politischen Stakeholdern mit der \u00dcberzeugung jeder Allergiker hat das Recht auf eine wirksame Behandlung insbesondere Kinder.",
        "fieldsOfInterest": [
            {
                "code": "FOI_HEALTH",
                "de": "Gesundheit",
                "en": "Health"
            },
            {
                "code": "FOI_HEALTH_MEDICINE",
                "de": "Arzneimittel",
                "en": "Medicine"
            },
            {
                "code": "FOI_HEALTH_OTHER",
                "de": "Sonstiges im Bereich \"Gesundheit\"",
                "en": "Other in the field of \"Health\""
            },
            {
                "code": "FOI_MEDIA_DIGITALIZATION",
                "de": "Digitalisierung",
                "en": "Digitalization"
            },
            {
                "code": "FOI_HEALTH_SUPPLY",
                "de": "Gesundheitsversorgung",
                "en": "Health supply"
            },
            {
                "code": "FOI_HEALTH_PROMOTION",
                "de": "Gesundheitsf\u00f6rderung",
                "en": "Health promotion"
            },
            {
                "code": "FOI_MEDIA",
                "de": "Medien, Kommunikation und Informationstechnik",
                "en": "Media, communication and information technology"
            }
        ],
        "typesOfExercisingLobbyWork": [
            {
                "code": "SELF_OPERATED_OWN_INTEREST",
                "de": "Die Interessenvertretung wird in eigenem Interesse selbst wahrgenommen",
                "en": "Interest representation is self-performed in its own interest"
            },
            {
                "code": "CONTRACTS_OPERATED_BY_THIRD_PARTY",
                "de": "Die Interessenvertretung wird in eigenem Interesse durch die Beauftragung Dritter wahrgenommen",
                "en": "Contracts are awarded to third parties to represent own interests of the company"
            }
        ]
    },
    "annualReports": {
        "annualReportLastFiscalYearExists": true,
        "annualReportPdfUrl": "https://www.lobbyregister.bundestag.de/media/44/32/344610/ALK_Jahresabschlussbericht-und-Testatsexemplar-2023.pdf",
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearStart": "2023-01-01"
    },
    "codeOfConduct": {
        "ownCodeOfConduct": false
    },
    "contracts": {
        "contracts": [],
        "contractsPresent": false
    },
    "donators": {
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalDonationsEuro": {
            "from": 0,
            "to": 0
        }
    },
    "employeesInvolvedInLobbying": {
        "employeeFTE": 0.1,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "financialExpenses": {
        "financialExpensesEuro": {
            "from": 10001,
            "to": 20000
        },
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "legislation": "GL2024",
    "lobbyistIdentity": {
        "address": {
            "city": "Hamburg",
            "country": {
                "code": "DE",
                "de": "Deutschland",
                "en": "Germany"
            },
            "nationalAdditional1": "ALK-Abell\u00f3 Arzneimittel GmbH",
            "street": "Friesenweg",
            "streetNumber": "38",
            "type": "NATIONAL",
            "zipCode": "22763"
        },
        "capitalCityRepresentationPresent": false,
        "contactDetails": {
            "emails": [
                {
                    "email": "lobbyregister@alk.net"
                }
            ],
            "phoneNumber": "+49407038450",
            "websites": [
                {
                    "website": "www.alk.de"
                }
            ]
        },
        "entrustedPersons": [
            {
                "firstName": "Tim",
                "lastName": "Schr\u00f6der",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Tobias",
                "lastName": "Str\u00fcve",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Detlef",
                "lastName": "G\u00e4rtner",
                "recentGovernmentFunctionPresent": false
            },
            {
                "academicDegreeBefore": "Dr.",
                "firstName": "Janina",
                "lastName": "Mette",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Justine",
                "lastName": "Ke\u00dfler",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Manuel",
                "lastName": "B\u00e4chle",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "entrustedPersonsPresent": true,
        "identity": "ORGANIZATION",
        "legalForm": {
            "code": "LF_GMBH",
            "de": "Gesellschaft mit beschr\u00e4nkter Haftung (GmbH)",
            "en": "Limited liability company (GmbH)"
        },
        "legalFormType": {
            "code": "JURISTIC_PERSON",
            "de": "Juristische Person",
            "en": "Legal person"
        },
        "legalRepresentatives": [
            {
                "academicDegreeBefore": "Dr.",
                "entrustedPerson": false,
                "firstName": "Flora",
                "function": "Gesch\u00e4ftsf\u00fchrerin",
                "lastName": "Beiche-Scholz",
                "recentGovernmentFunctionPresent": false
            },
            {
                "entrustedPerson": false,
                "firstName": "Hendrik",
                "function": "Senior Commercial Director",
                "lastName": "Grage",
                "recentGovernmentFunctionPresent": false
            },
            {
                "entrustedPerson": false,
                "firstName": "Antonio",
                "function": "Regional General Manager Germany, Austria, Switzerland",
                "lastName": "Pusole",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "membersPresent": false,
        "memberships": [
            {
                "membership": "Bundesverband Managed Care"
            },
            {
                "membership": "Critical Medicines Alliance (EU - HERA)"
            }
        ],
        "membershipsPresent": true,
        "name": "ALK-Abell\u00f3 Arzneimittel GmbH"
    },
    "mainFundingSources": {
        "mainFundingSources": [
            {
                "code": "MFS_ECONOMIC_ACTIVITY",
                "de": "Wirtschaftliche T\u00e4tigkeit",
                "en": "Economic activity"
            }
        ],
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "membershipFees": {
        "individualContributors": [],
        "individualContributorsPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalMembershipFees": {
            "from": 0,
            "to": 0
        }
    },
    "publicAllowances": {
        "publicAllowancesPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "registerEntryDetails": {
        "detailsPageUrl": "https://www.lobbyregister.bundestag.de/suche/R004956/39303",
        "fiscalYearUpdate": {
            "lastFiscalYearUpdate": "2024-08-16T14:46:12.000+02:00"
        },
        "pdfUrl": "https://www.lobbyregister.bundestag.de/media/67/70/344611/Lobbyregister-Detailansicht-R004956-2024-08-16_14-46-12.pdf",
        "validFromDate": "2024-08-16T14:46:12.000+02:00",
        "version": 5
    },
    "registerEntryId": 39303,
    "registerNumber": "R004956",
    "regulatoryProjects": {
        "regulatoryProjects": [
            {
                "affectedLaws": [],
                "affectedLawsPresent": false,
                "description": "Das Ziel der Initiative Allergiescreening Deutschland ist es die Fr\u00fcherkennung und fr\u00fchzeitige Behandlung von Allergieerkrankungen in Deutschland zu optimieren. Die Initiative besch\u00e4ftig sich insbesondere mit der Fragestellung, auf welche Weise Allergiescreenings zu einer Verbesserung der Versorgung von Kindern und Jugendlichen mit Allergieerkrankungen beitragen k\u00f6nnen.  \r\nEs ist Anliegen der Initiative, die Einf\u00fchrung von Allergiescreenings in die U-Untersuchungen (G-BA Kinderrichtlinien) zu unterst\u00fctzen.",
                "draftBillPresent": false,
                "fieldsOfInterest": [
                    {
                        "code": "FOI_HEALTH",
                        "de": "Gesundheit",
                        "en": "Health"
                    },
                    {
                        "code": "FOI_HEALTH_PROMOTION",
                        "de": "Gesundheitsf\u00f6rderung",
                        "en": "Health promotion"
                    }
                ],
                "printedMatters": [],
                "printedMattersPresent": false,
                "regulatoryProjectNumber": "RV0005727",
                "statements": [],
                "title": "Einf\u00fchrung eines Allergiescreening f\u00fcr Kinder- und Jugendliche"
            }
        ],
        "regulatoryProjectsPresent": true
    },
    "statements": {
        "statements": [],
        "statementsPresent": false
    }
}